Most of the big names will be there! I wish there were a way to get the detractors and unbelievers to go, so they'd get the message that the evidence shows that the ORIGINAL type of CFS is post-viral and not psychiatric. (Unfortunately, too many sloppy and/or uninformed doctors have diagnosed any case of fatigue as CFS, regardless of origin.)
Source: HHV-6 Foundation
Date: March 2008
URL: http://www.hhv-6conference.com
http://www.hhv-6conference.com/satellite/
http://www.hhv-6conference.com/satellite/regform_cfsonly.php
http://www.hhv-6conference.com/program/index.php
6th International Conference on HHV-6 & 7
-----------------------------------------
June 19-22nd 2008, Baltimore, MD
Satellite Conference on Viruses in CFS
--------------------------------------
Baltimore, Maryland USA - June 22nd-23rd, 2008
Due to new research suggesting the possibility of a viral etiology in a
subset of CFS patients, we are sponsoring a special satellite session
June 22nd-23rd titled 'Viruses in CFS'.
Sun - June 22nd
15:10-17:00 Infections in CNS Dysfunction/CFS
Mon - June 23rd
09:00-12:00 Viral Infections in CFS
13:00-15:00 Viral Infections in CFS
15:10-17:00 Infections in CNS Dysfunction/CFS
Speakers to include (list incomplete):
* Jose G. Montoya, MD, Stanford University, USA (HHV-6 & EBV)
* John Chia, MD, EV Med Research, Lomita, CA, USA (enterovirus)
* Andrew Lloyd, MD, UNSW School of Medical Sciences (post viral fatigue)
* Anthony Komaroff, MD, Harvard Medical School, Boston, USA (infections in
CFS)
* Brigitte Huber, PhD, Tufts University, Boston, MA, USA (retrovirus)
* Keizo Tomanga, PhD, DVM, Osaka University, Japan (borna virus)
* Nancy Klimas, MD, University of Miami, Florida, USA (immune markers in
viral infections vs CFS)
* Kazuhiro Kondo, MD, PhD, Jikei University School of Medicine, Tokyo, Japan
(HHV-6 & 7)
* Ron Glaser, PhD, Ohio State University Medical Center, Columbus, Ohio, USA
(EBV)
* Jonthan Kerr, MD, PhD, St. George's, University of London, UK (parvovirus,
gene expression)
* Dan Peterson, MD, Sierra Internal Medicine, Incline Village, USA (novel
viruses in CFS)
* Birgitta Evengard, MD, PhD, Umea University, Uma, Sweden (viral markers in
CFS)
* Suzanne Vernon, PhD, CFIDS Association of America, USA
Satellite Conference Topics:
* HHV-6 & 7 co-infections in CFS
* Borna virus in CFS
* EBV in CFS
* Post infective CFS/Post Viral Fatigue
* Parovirus B-19 in CFS
* Retrovirus K-18
* Entero-virus
Program Committee
* Dharam Ablashi, DVM, MS, Dip. Bact., HHV-6 Foundation, USA
* John Chia, MD, EV Med Research, Lomita, CA, USA
* Jonthan Kerr, MD, St. George’s, University of London, UK
* Jose G. Montoya, MD, Stanford University, USA
* Andrew Lloyd, MD, UNSW School of Medical Sciences
* Anthony Komaroff, MD, Harvard Medical School, Boston, USA
Advisory Committee (Committee still in formation)
* Leonard Archard, PhD, Imperial College, London, USA
* Robert Gallo, PhD, Institute for Human Virology, Baltimore, USA
* Ron Glaser, PhD, Ohio State University Medical Center, Columbus, Ohio, USA
* Sudhir Gupta, MD, PhD, MACP, University of California Irvine, Irvine, USA
* Brigitte Huber, PhD, Tufts University, Boston, MA, USA
* Kazuyoshi Ikuta, PhD, Hokkaido Unversity, Japan
* Nancy Klimas, MD, University of Miami, Florida, USA
* Kazuhiro Kondo, MD, PhD, Jikei University School of Medicine, Tokyo, Japan
* Martin Lerner, MD, Wayne State University, Michigan, USA
* Lieve Naesens, PhD, Rega Institute for Medical Research, Leuven, Belgium
* Dan Peterson, MD, Sierra Internal Medicine, Incline Village, USA
* Nigel Pluck, MD, Roche Products, Ltd., Hertfordshire, UK
* Suzanne Vernon, PhD, CFIDS Association of America, USA
* Koichi Yamanishi, MD, PhD, National Institute of Biomedical Innovation,
Osaka, Japan
Organizing Committee
* Dharam Ablashi, DVM, MS, Dip. Bact., HHV-6 Foundation, USA (Chair)
* Courtney Hischier, HHV-6 Foundation, USA
* Anthony Komaroff, MD, Harvard Medical School, Boston, USA
* Kristin Loomis, HHV-6 Foundation, USA
Interested in Just the Viral Infections in CFS Conference?
Attendees who are interested primarily in the role of HHV-6 in CNS
Dysfunction and CFS may choose to attend just the satellite conference, or
for a discount rate, arrive early and attend the last day of the main
conference which will be devoted exclusively to HHV-6 in CNS Dysfunction.
Viruses in CFS Registration Form
http://www.hhv-6conference.com/satellite/regform_cfsonly.php
- - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - - -
6th International Conference on HHV-6 & 7
-----------------------------------------
Conference Co-Chairs
* Robert Gallo, MD, Institute for Human Virology, Baltimore, USA
* Philip Pellett, PhD, Wayne State University, School of Medicine,
Detroit, USA
Program Committee Co-Chairs
* Dharam Ablashi, HHV-6 Foundation, USA
* Steve Jacobson, NINDS/NIH, USA
* Philip Pellett, PhD, Wayne State University, School of Medicine,
Detroit, USA
* William Theodore, MD, National Institute of Neurological Disorders &
Stroke, NIH, Bethesda, USA
Program Committee
* Dharam Ablashi, DVM, HHV-6 Foundation, Santa Barbara, California, USA
* Henri Agut, MD, PhD, Hospital Pitie-Salpetriere , Paris, France
* Roberto Alvarez-LaFuente, MD, Hospital Clinico San Carlos, Madrid, Spain
* Louis Flamand, PhD, University Laval, Quebec, Canada
* Niza Frankel, PhD, Tel Aviv University, Tel Aviv, Israel
* Robert Gallo, MD, Institute of Virology, University of Maryland, USA
* Ursula Gompels, PhD, London School of Tropical Medicine, London, UK
* Caroline Hall, MD, University of Rochester, Rochester, USA
* Steve Jacobson, PhD, National Institute of Neurological Disorders &
Stroke/NIH, USA
* Anthony Komaroff, MD, Harvard Medical School, Boston, USA
* Paolo Lusso, MD, PhD, San Raffaele Institute, Milan, Italy
* Jose G. Montoya, MD, Stanford University, USA
* Lieve Naesens, PhD, Rega Institute for Medical Research, Leuven, Belgium
* Philip Pellett, PhD, Cleveland Clinic, Ohio USA
* William Theodore, MD, National Institute of Neurological Disorders &
Stroke, NIH, Bethesda, USA
* Koichi Yamanishi, MD, PhD, National Institute of Biomedical Innovation,
Osaka, Japan
* Tetsushi Yoshikawa, MD, Nagoya University School of Medicine, Toyoake
Aichi, Japan
Advisory Committee
* Yoshizo Asano, MD, PhD, Fujita Health University, Toyoake, Aichi, Japan
* Edward Bromfield, MD, Harvard University, Boston, USA
* Don Carrigan, PhD, Wisconsin Viral Research, Milwaukee, USA
* Mary Caserta, MD, University of Rochester School of Medicine, Rochester,
NY, USA
* Erik De Clercq, MD, PhD, Rega Institute for Medical Research, Leuven,
Belgium
* Vincent Descamps, MD, PhD, Bichat Claude Bernard Hospital, France
* Leon Epstein, MD, Northwestern University, Chicago, USA
* Nihal De Lanerolle, MD, PhD, Yale University, New Haven, CT USA
* Steve Dewhurst, PhD, University of Rochester, USA
* Robert Gallo, MD, Institute for Human Virology, Baltimore, USA
* Claude Genain, MD, California Pacific Medical Center Research Institute,
San Francisco, USA
* Ron Glaser, PhD, Ohio State University Medical Center, Columbus, Ohio, USA
* Andrew Goodman, MD, University of Rochester Medical Center, Rochester, USA
* Sudhir Gupta, MD, PhD, MACP, University of California Irvine, Irvine, USA
* Kazuhiro Kondo, MD, PhD, Jikei University School of Medicine, Tokyo, Japan
* Uwe Kuhl, MD, PhD, Charite-Univeristy Medicine Berlin, Germany
* Gerhard Krueger, MD, PhD, University of Texas, Houston Medical School, USA
* Janos Luka, PhD, Bioworld Consulting Laboratories, Maryland, USA
* Irmeli Lautenschlager, MD, PhD, Helsinki University, Central Hospital,
Finland
* Per Ljungman, MD, PhD, Karolinska Institute, Sweden
* Mauro Malnati, MD, San Raffaele Scientific Institute, Milan, Italy
* Peter Medveczky, MD, University of South Florida College of Medicine, USA
* David Mock, MD, University of Rochester, USA
* Yasauki Mori, MD, PhD, National Institute of Biomedical Innovation, Osaka,
Japan
* Gary Pearson, PhD, Georgetown Univ. (retired) USA
* Dan Peterson, MD, Sierra Internal Medicine, Incline Village, USA
* Nigel Pluck, MD, Roche Products, Ltd., Hertfordshire, UK
* Mark Prichard, PhD, University of Alabama School of Medicine, Birmingham,
USA
* Marvin Reitz, PhD, Institute of Human Virology, Baltimore, USA
* Silvie Ranger-Rogez, MD, PhD, Faculte de Pharmacie, Limoges Cedex, France
* Shlomo Shinnar, MD, PhD, Albert Einstein College of Medicine, Bronx, NY,
USA
* Marshall Williams, PhD, Ohio State University, Columbus, Ohio, USA
* Danielle Zerr, MD, MPH, Seattle Children's Hospital, Seattle, USA
Organizing Committee
* Dharam Ablashi, DVM, MS, Dip. Bact., HHV-6 Foundation, USA
* Courtney Hischier, HHV-6 Foundation, USA
* Steve Jacobson, PhD, National Institute of Neurological Disorders & Stroke,
NIH, USA
* Kristin Loomis, HHV-6 Foundation, USA
--------
(c) 2008 HHV-6 Foundation
No comments:
Post a Comment